Natco Pharma Limited has informed the Exchange regarding a press release dated May 22, 2021, titled "NATCO receives USFDA approval for Lenalidomide Capsules".
Press Release May 22 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from NATCO Pharma
- Press Release May 21 2021
- Press Release May 17 2021
- Press Release May 03 2021
- Press Release Apr 26 2021
- NATCO Pharma receives tentative approval for Ibrutinib tablets (generic for IMBRUVICA) ANDA in the US market
Later from NATCO Pharma
- Press Release Jun 14 2021
- Press Release Jul 07 2021
- Press Release Aug 03 2021
- Press Release Aug 20 2021
- Press Release Sep 02 2021
Follow NATCO Pharma into a list and get an email when it puts out news.
Follow NATCO Pharma